Follow
Blake T Langlais
Blake T Langlais
Mayo Clinic, Division of Clinical Trials and Biostatistics
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Telephone cardiopulmonary resuscitation is independently associated with improved survival and improved functional outcome after out-of-hospital cardiac arrest
Z Wu, M Panczyk, DW Spaite, C Hu, H Fukushima, B Langlais, J Sutter, ...
Resuscitation 122, 135-140, 2018
1002018
Personality changes during the transition from cognitive health to mild cognitive impairment
RJ Caselli, BT Langlais, AC Dueck, BR Henslin, TA Johnson, ...
Journal of the American Geriatrics Society 66 (4), 671-678, 2018
632018
Neuropsychological decline up to 20 years before incident mild cognitive impairment
RJ Caselli, BT Langlais, AC Dueck, Y Chen, Y Su, DEC Locke, ...
Alzheimer's & Dementia, 2019
472019
Barriers to telephone cardiopulmonary resuscitation in public and residential locations
H Fukushima, M Panczyk, DW Spaite, V Chikani, C Dameff, C Hu, ...
Resuscitation 109, 116-120, 2016
362016
Telephone CPR instructions in emergency dispatch systems: qualitative survey of 911 call centers
J Sutter, M Panczyk, DW Spaite, JME Ferrer, J Roosa, C Dameff, ...
Western Journal of Emergency Medicine 16 (5), 736, 2015
332015
Barriers to patient positioning for telephone cardiopulmonary resuscitation in out-of-hospital cardiac arrest
BT Langlais, M Panczyk, J Sutter, H Fukushima, Z Wu, T Iwami, D Spaite, ...
Resuscitation 115, 163-168, 2017
292017
Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype
AJ Desai, M Dong, BT Langlais, AC Dueck, LJ Miller
The American Journal of Clinical Nutrition 106 (2), 447-456, 2017
202017
The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms
K Gowin, BT Langlais, HE Kosiorek, A Dueck, D Millstine, J Huberty, ...
Cancer medicine 9 (24), 9445-9453, 2020
182020
Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations
TT DeLeon, DR Almquist, BR Kipp, BT Langlais, A Mangold, JL Winters, ...
PLoS One 15 (3), e0230306, 2020
172020
Depressive symptoms and myeloproliferative neoplasms: understanding the confounding factor in a complex condition
L Padrnos, R Scherber, H Geyer, BT Langlais, AC Dueck, HE Kosiorek, ...
Cancer medicine 9 (22), 8301-8309, 2020
162020
Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?
BT Langlais, H Geyer, R Scherber, RA Mesa, AC Dueck
Leukemia & lymphoma 60 (2), 402-408, 2019
152019
Subjective cognitive impairment and the broad autism phenotype
RJ Caselli, BT Langlais, AC Dueck, DEC Locke, BK Woodruff
Alzheimer Disease & Associated Disorders 32 (4), 284-290, 2018
132018
Statewide implementation of a standardized prearrival telephone CPR program is associated with increased bystander CPR and survival from out-of-hospital cardiac arrest
B Bobrow, M Panczyk, U Stolz, M Sotelo, T Vadeboncoeur, J Sutter, ...
Circulation 130 (suppl_2), A1-A1, 2014
122014
Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data
B Langlais, GL Mazza, G Thanarajasingam, LJ Rogak, B Ginos, N Heon, ...
Journal of pain and symptom management 63 (2), 311-320, 2022
62022
Peppermint oil to improve visualization in screening colonoscopy: A randomized controlled clinical trial
I Shah, NJ Baffy, JL Horsley-Silva, BT Langlais, KC Ruff
Gastroenterology Research 12 (3), 141, 2019
62019
Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies
GL Mazza, KL Kunze, BT Langlais, HE Kosiorek, TA DeWees, HL Geyer, ...
Leukemia & lymphoma, 2019
52019
Sleep and psychiatric disturbance in chronic Philadelphia negative myeloproliferative neoplasms
KL Gowin, BT Langlais, HE Kosiorek, A Dueck, D Millstine, J Huberty, ...
Blood 130, 4189, 2017
42017
Nutrition and supplement use characteristics in the myeloproliferative neoplasms: results from the Nutrient Survey
RM Scherber, BT Langlais, H Geyer, A Dueck, H Kosoriek, C Johnston, ...
Blood 130, 2193, 2017
42017
Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period
MK Lee, E Basch, SA Mitchell, LM Minasian, BT Langlais, ...
Quality of Life Research 32 (7), 2047-2058, 2023
32023
Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment …
HE Kosiorek, RM Scherber, HL Geyer, S Verstovsek, BT Langlais, ...
British journal of haematology 198 (6), 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20